For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Urodynamic Devices Market By Product Type (Uroflowmetry Equipment, Electromyograph, Urodynamic Systems, Urodynamic Catheters, Urodynamic Pumps And Transducer Sets, Others), By End-User (Hospitals And Urology Clinics, Ambulatory Surgery Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2027 owing to rising prevalence of kidney disorders, increasing prevalence of bladder cancers
Global Urodynamic Devices Market was valued at USD 403.35 Million in 2021, growing at a CAGR of 6.03% during the forecast period from 2022 to 2027 to reach USD 573. 16 Million by 2027. The Urodynamic Devices market is witnessing positive growth owing to the rising prevalence of kidney disorders, increasing prevalence of bladder cancers, technological advancements in Urodynamic Equipment, thereby contributing to the growth of the Urodynamic Devices market during the forecast period from 2021-2026.
Urodynamic Devices Market Dynamics:
The rising prevalence of kidney disorders is the key driving factor for the Urodynamic Devices market.
For instance, as per the World Kidney Day organization in 2020, kidney disease is a non-communicable disease affecting about 850 million people across the world. as per the same source, about one in ten adults are observed to be suffering from chronic kidney disease which is projected to become the fifth most common cause of life loss globally by the year 2040.
As per the National Kidney Foundation 2021, in 2020 about 10% of the population globally suffered from chronic kidney diseases and millions of people were dying every year as they did not have enough access to affordable treatments. As per the same source, about over 2 million people had received treatment with dialysis or kidney transplant in the year 2020 but this number represents only 10% of the people requiring treatment to stay alive.
According to the Centers for Disease Control and Prevention 2021, more than one in seven, that is 15% of the US people or 37 million people were estimated to be have suffered from chronic kidney disorders in the year 2020.
As per the Kidney Care UK in 2020, around 3 million people in the United Kingdom were suffering from chronic kidney diseases. Also as per the same source, there are about 40-45,000 premature deaths in the UK every year due to CKD.
Therefore, due to the rising prevalence of kidney disorders, there will be an increase in the demand for urodynamic devices, thereby fueling the market growth for Urodynamic Devices.
However, the high cost of the urodynamic devices and tests and complications associated with urodynamic catheters such as pain, patient anxiety, and injury may be certain limiting factors of the Urodynamic Devices market growth.
The unprecedented COVID-19 outbreak had a profound impact on the market for urodynamic devices. Owing to the lockdown restrictions posed during the COVID-19 pandemic, there were reduced patients visits, and all other surgical/diagnostic procedures were temporarily paused, giving more attention to the COVID-19 inflicted patients. However, as a result of relaxation observed in the COVID-19 lockdown and the approvals and launches in the urodynamic devices arena, there had been normalcy attained in the growth of the urodynamic devices market.
Urodynamic Devices Market Segment Analysis:
Urodynamic Devices Market By Product Type (Uroflowmetry Equipment, Electromyograph, Urodynamic Systems, Urodynamic Catheters, Urodynamic Pumps and Transducer Sets, Others), By End-User (Hospitals and Urology Clinics, Ambulatory Surgery Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Product Type segment of the Urodynamic Devices market, Electromyograph are estimated to hold a higher share in the Urodynamic Devices market during the forecast period (2021-2026). This can be attributed to the specific features associated with these devices.
The demand for electromyography devices will improve owing to the rising prevalence of kidney disorders and bladder cancers globally, the approval and launch of electromyography devices, and the increased research and development on electromyography devices.
For instance, as per the World Bladder Cancer Patient Coalition in the year 2020, about 573,278 people are suffering from bladder cancer globally. As per the same source, bladder cancer is considered the tenth most commonly diagnosed cancer in the world.
As per the National Institute of Health in the year 2020, the rate of new cases of bladder cancer was 19.7 per 100,000 men and women per year. As per the same source, approximately 2.4 percent of men and women will be diagnosed with bladder cancer at some point during their lifetime, based on 2016-2018 data.
Furthermore, according to the International Society of Nephrology 2021, in the year 2020 more than 850 million people were suffering from chronic kidney disorders.
Hence, all the aforementioned factors will contribute to the growth of electromyograph devices in Urodynamic Devices market.
North America is expected to dominate the overall Urodynamic Devices Market:
Among all the regions, North America is expected to account for the largest share in the Global Urodynamic Devices market. The rising prevalence of renal disorders and urinary bladder cancers, growing products approvals, and launches along favorable reimbursement policies are the key factor contributing to the Urodynamic Devices market in the country.
According to the National Institute of Health in the year 2020, 1 in 7 adults in the United States was suffering from chronic kidney disease. This accounts for a total of 37 million Americans.
Also, as per the Centers for Disease Control and Prevention 2021, in the year 2020 chronic kidney disorders are more common in people aged 65 years or older (38%) than in people aged 45-64 years (12%) or 18-44 years (6%) for the United States.
As per the American Journal of Kidney Diseases 2020, End-Stage Renal Disease (ESRD) prevalence in the United States remains one of the highest in the world at 2,242 cases per million population in 2018.
As per the American Cancer Society's estimates for bladder cancer in the United States in the year 2020, about 83,730 new cases of bladder cancer were diagnosed (about 64,280 in men and 19,450 in women).
Thus, all the above-mentioned factors are anticipated to propel the market for Urodynamic Devices in the United States region.
Urodynamic Devices Market Key Players:
Some of the key market players operating in the Urodynamic Devices market include B Braun Meslungen AG, BestMedical, MINZE HEALTH, Santron Meditronic., Potent Medical, Laborie, MEDKONSULT medical technology s.r.o., The Prometheus Group®, HCItalia srl, DeltaMed, MEDICA S.P.A, Aymed Medical Technology, EV.SERVICE ITALIA, tic Medizintechnik GmbH & Co. KG, Creo Medical Ltd, Stericom Ltd., Amecath Medical Technologies, Cook, Well Lead Medical Co., Ltd, and others.
Recent Developmental Activities in the Urodynamic Devices Market:
- In March 2022, A video urodynamic lab was inaugurated at the Delhi government-run Lok Nayak Hospital by Health Minister. The lab is capable of taking real-time pictures of the urinary tract and bladder, which also provides immediate biofeedback.
Key Takeaways from the Urodynamic Devices Market Report Study
- Market size analysis for current Urodynamic Devices market size (2021), and market forecast for 5 years (2022-2027)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Urodynamic Devices market.
- Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the global Urodynamic Devices market.
- Various opportunities available for the other competitor in the Urodynamic Devices market space.
- What are the top performing segments in 2021? How these segments will perform in 2027.
- Which is the top-performing regions and countries in the current Urodynamic Devices market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for Urodynamic Devices market growth in the coming future?
Target Audience who can be benefited from this Urodynamic Devices Market Report Study
- Urodynamic Devices products providers
- Research organizations and consulting companies
- Urodynamic Devices-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and Traders dealing in Urodynamic Devices
- Various End-users who want to know more about the Urodynamic Devices market and latest technological developments in the Urodynamic Devices market.
Frequently Asked Questions for the Urodynamic Devices Market:
1. What are Urodynamic Devices?
Urodynamic Devices are created to investigate the function of the urinary tract by taking physical measurements of bladder pressure and flow rates.
2. What is the market for Global Urodynamic Devices?
Global Urodynamic Devices Market was valued at USD 403.35 Million in 2021, growing at a CAGR of 6.03% during the forecast period from 2022 to 2027 to reach USD 573. 16 Million by 2027.
3. What are the drivers for the Global Urodynamic Devices Market?
The Urodynamic Devices market is witnessing positive market growth owing to the rising prevalence of kidney disorders, increasing prevalence of bladder cancers, technological advancements in Urodynamic Equipment, thereby contributing to the growth of the Urodynamic Devices market during the forecast period from 2022-2027
4. Who are the key players operating in the Global Urodynamic Devices Market?
Some of the key market players operating in the Urodynamic Devices market include B Braun Meslungen AG, BestMedical, MINZE HEALTH, Santron Meditronic., Potent Medical, Laborie, MEDKONSULT medical technology s.r.o., The Prometheus Group®, HCItalia srl, DeltaMed, MEDICA S.P.A, Aymed Medical Technology, EV.SERVICE ITALIA, tic Medizintechnik GmbH & Co. KG, Creo Medical Ltd, Stericom Ltd., Amecath Medical Technologies, Cook, Well Lead Medical Co., Ltd, and others.
5. Which region has the highest share in Urodynamic Devices Market?
North America is expected to hold the highest share in the revenue in the Urodynamic Devices market during the forecast period. The rising prevalence of renal disorders and urinary bladder cancers, growing products approvals, and launches along with favorable reimbursement policies are the key factor contributing to the Urodynamic Devices market in the country are expected to aid in the growth of the North America Urodynamic Devices Market.